INCY, a molecular and genomics company that we featured in our FusionIQ Investor Chart of the Week several weeks ago, continued to breakout to new price highs yesterday on above average volume. Shares continue to look bullish with an $ 18.00 target and can be bought here and on pullbacks.
|